JeffreyGoldberg
MD, PhD
Location
Stanford, CA, USA
Current Organization
Stanford University
Biography
Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology and Director of the Byers Eye Institute at Stanford University and a member of the National Academy of Medicine. His clinical effort is focused on patients in need of medical or surgical intervention for glaucoma and other retinal and optic nerve diseases, as well as cataract. His research is directed at neuroprotection and regeneration of retinal ganglion cells and the optic nerve, a major unmet need in glaucoma and other optic neuropathies, and his laboratory is developing novel molecular, stem cell, and nanotherapeutics approaches for eye repair. Dr. Goldberg received his B.S. magna cum laude from Yale University, and his M.D. and Ph.D. from Stanford University where he made significant discoveries about the failure of optic nerve regeneration. He did his clinical training in ophthalmology and then in glaucoma at the Bascom Palmer Eye Institute, and was awarded a fellowship from the Heed Foundation. He was named the 2010 Scientist of the Year by the Hope For Vision foundation and received the Cogan award from the Association for Research in Vision and Ophthalmology in 2012. He was elected in 2010 to the American Society of Clinical Investigation, an honorary society of physician-scientists, and in 2021 to the American Ophthalmological Society. He directs an NIH-funded research laboratory and is one of the scientists funded by the National Eye Institute’s Audacious Goals Initiative.
Grants
Grants Featuring
Jeffrey Goldberg, MD, PhD
National Glaucoma Research
Manipulating Kruppel-Like Factors for RGC Regeneration
Active Dates
April 01, 2010 - March 31, 2012
Principal Investigator
Jeffrey Goldberg, MD, PhD
Manipulating Kruppel-Like Factors for RGC Regeneration
Active Dates
April 01, 2010 - March 31, 2012
Principal Investigator
Jeffrey Goldberg, MD, PhD
BrightFocus Foundation
Neuroprotection and Neuroenhancement in Glaucoma
Active Dates
May 01, 2022 - April 30, 2025
Principal Investigator
Jeffrey Goldberg, MD, PhD
Neuroprotection and Neuroenhancement in Glaucoma
Active Dates
May 01, 2022 - April 30, 2025
Principal Investigator
Jeffrey Goldberg, MD, PhD
National Glaucoma Research
Neuroregenerative Strategies in Glaucoma
Active Dates
July 01, 2015 - December 31, 2019
Principal Investigator
Jeffrey Goldberg, MD, PhD
Neuroregenerative Strategies in Glaucoma
Active Dates
July 01, 2015 - December 31, 2019
Principal Investigator
Jeffrey Goldberg, MD, PhD
National Glaucoma Research
Early Phase Testing of Regenerative Therapies in Glaucoma
Active Dates
April 01, 2014 - March 31, 2015
Principal Investigator
Jeffrey Goldberg, MD, PhD
Early Phase Testing of Regenerative Therapies in Glaucoma
Active Dates
April 01, 2014 - March 31, 2015
Principal Investigator
Jeffrey Goldberg, MD, PhD